Loading clinical trials...
Loading clinical trials...
Prediction of Acute Heart or Kidney Injury With Cardiovascular-renal Biomarkers in Patients Hospitalised for Severe or Critical Covid-19 Infection
Conditions
Interventions
Biological samples specific to research
Clinical examination
+1 more
Locations
2
France
CHRU de Nancy
Nancy, France
CHRU de Nancy
Vandœuvre-lès-Nancy, France
Start Date
April 27, 2020
Primary Completion Date
December 19, 2020
Completion Date
March 26, 2021
Last Updated
October 1, 2021
NCT07278388
NCT07123727
NCT07013903
NCT05040659
NCT06391489
NCT06992401
Lead Sponsor
Central Hospital, Nancy, France
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions